Gene · 5927
Papers1,684
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,684
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of RNA modification in urological cancers: mechanisms and clinical potential. | Discov Oncol | 2023 | 38117350 | PubTator, text mining | PubMed |
| Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research. | Front Mol Biosci | 2023 | 38028543 | PubTator, text mining | PubMed |
Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study. | Front Immunol | 2023 | 38022513 | PubTator, text mining | PubMed |
| A De Novo Frameshift Mutation in RPL5 with Classical Phenotype Abnormalities and Worsening Anemia Diagnosed in a Young Adult-A Case Report and Review of the Literature. | Medicina (Kaunas) | 2023 | 38004002 | PubTator, text mining | PubMed |
| In Vitro Models of Head and Neck Cancer: From Primitive to Most Advanced. | J Pers Med | 2023 | 38003890 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in Epigenetic Dysregulation in Glioblastoma Development. | Int J Mol Sci | 2023 | 38003512 | PubTator, text mining | PubMed |
| MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications. | Biomolecules | 2023 | 38002272 | PubTator, text mining | PubMed |
| Risk of Second Tumors in Retinoblastoma Survivors after Ionizing Radiation: A Review. | Cancers (Basel) | 2023 | 38001596 | PubTator, text mining | PubMed |
| Disruption of the autism gene and chromatin regulator KDM5A alters hippocampal cell identity. | Sci Adv | 2023 | 37992166 | PubTator, text mining | PubMed |
| Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype. | Sci Adv | 2023 | 37992163 | PubTator, text mining | PubMed |
Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer. | Signal Transduct Target Ther | 2023 | 37973901 | PubTator, text mining | PubMed |
| Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51. | Nat Commun | 2023 | 37973845 | PubTator, text mining | PubMed |
| The role of genetic and epigenetic factors in determining the risk of spinal fragility fractures: new insights in the management of spinal osteoporosis. | Quant Imaging Med Surg | 2023 | 37969626 | PubTator, text mining | PubMed |
| HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes. | bioRxiv | 2023 | 37961464 | PubTator, text mining | PubMed |
| Cannflavins A and B with Anti-Ferroptosis, Anti-Glycation, and Antioxidant Activities Protect Human Keratinocytes in a Cell Death Model with Erastin and Reactive Carbonyl Species. | Nutrients | 2023 | 37960218 | PubTator, text mining | PubMed |
| Cancer of unknown primary histologically, genetically and spatially diagnosed as left ovary‑derived cancer: A case report. | Oncol Lett | 2023 | 37927414 | PubTator, text mining | PubMed |
| Case report: Identification of potential prognosis-related LAG3 overexpression and DICER1 mutation in pituitary carcinoma: two cases. | Front Neurosci | 2023 | 37901430 | PubTator, text mining | PubMed |
| A Chromosome 9p24.1 Amplification in Colorectal Cancer with Metastases to the Kidney and Adrenal Gland: A Case Report. | Case Rep Oncol | 2023 | 37900784 | PubTator, text mining | PubMed |
| Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities. | Cancers (Basel) | 2023 | 37894343 | PubTator, text mining | PubMed |
| Enhanced Transcriptional Signature and Expression of Histone-Modifying Enzymes in Salivary Gland Tumors. | Cells | 2023 | 37887281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5927/papers?page=7